(Q37201689)

18 August 2017

Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil (English)

1 reference

18 August 2017

1 reference

Takashi Sakugawa

1

1 reference

18 August 2017

Masatomo Miura

2

1 reference

18 August 2017

Nobuo Hokama

3

1 reference

18 August 2017

Toshio Suzuki

4

1 reference

18 August 2017

Tomonori Tateishi

5

1 reference

18 August 2017

Tsukasa Uno

6

1 reference

18 August 2017

language of work or name

English

0 references

publication date

23 January 2009

1 reference

British Journal of Clinical Pharmacology

18 August 2017

1 reference

18 August 2017

67

1 reference

18 August 2017

5

1 reference

18 August 2017

535-540

1 reference

The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Organic anion-transporting polypeptide (OATP) transporter family and drug disposition

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Transporters and xenobiotic disposition

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

The effect of rifampin administration on the disposition of fexofenadine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16455) and its enantiomers in healthy male volunteers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Functional characterization of monocarboxylic acid, large neutral amino acid, bile acid and peptide transporters, and P-glycoprotein in MDCK and Caco-2 cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Fexofenadine transport in Caco-2 cells: inhibition with verapamil and ritonavir

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686070

Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma

3 September 2018

1 reference

12 December 2020

Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug

1 reference

12 December 2020

Determination of fexofenadine enantiomers in human plasma with high-performance liquid chromatography

1 reference

12 December 2020

Pharmacokinetics of fexofenadine enantiomers in healthy subjects

1 reference

12 December 2020

10.1111/J.1365-2125.2009.03396.X

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19552748

1 reference